Dynex Capital, Inc. (DX) — closed signal from November 5, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on February 3, 2026 — +7.3% at the close.
Predicted vs. what happened
What happened
Reached its target in 72 days.
The thesis — published November 5, 2025
Dynex is a mortgage investment company seen as solid, with strong score 85 on core health and 97 on market mood. As interest rates cool, both analyst views call for a steady, short-term move. Buying pressure looks steady, the recent average price is rising, and price swings have been small. New portfolio growth updates and a New York office add capacity. We expect steady income plus modest gains over about three months to balance tech risk.
Primary drivers
- Strong company health (85) and very positive market mood (97) support gains.
- Recent average price is rising, and day-to-day price moves have been mild.
- Updates show portfolio growth; new New York office should boost capabilities.
- Plan aims for income plus steady gains over about three months.
How it played out
DX: target reached in 72 days
Lyra published DX at $13.08 on 2025-11-05, with a short-term window ending 2026-02-03. The thesis expected 12% growth. It pointed to company health of 85, market mood of 97, a rising recent average price, mild day-to-day moves, portfolio growth updates, and a New York office adding capacity.
Inside the window, DX reached a peak of $14.93 on 2026-01-28. That was above the $14.29 target, with a peak gain of 14.1%. The target was reached in 72 days. DX ended the window at $14.04. The thesis played out.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.